Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR). Cardiovasc Drugs Ther. 2020 06; 34(3):357-370.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Amyloid Neuropathies, Familial
Canada
Cardiomyopathies
Cause of Death
Disease Progression
Early Termination of Clinical Trials
Europe
Exercise Tolerance
Female
Genetic Predisposition to Disease
Humans
Male
Middle Aged
Mutation
Phenotype
Prealbumin
Recovery of Function
RNA, Small Interfering
RNAi Therapeutics
Time Factors
Treatment Outcome
United States

authors with profiles

Daniel P Judge